Medicare Enrolled
Dr. Carl Klutke, MD
Urology Physician · Asheville, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Klutke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Klutke?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Klutke
Dr. Carl Klutke is an urology physician in Asheville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Klutke performed 5,717 Medicare services across 2,348 unique beneficiaries.
Between the years covered by Open Payments, Dr. Klutke received a total of $11,281 from 43 pharmaceutical and/or device companies across 180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Klutke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in NC
$11,281 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,717
Medicare services
Top 14% in NC for urology physician
2,348
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~286 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,351 | $2 | $9 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,208 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
649 | $90 | $320 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
238 | $177 | $668 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
223 | $60 | $216 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
195 | $112 | $501 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
185 | $8 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $137 | $685 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
56 | $65 | $363 |
| Simple change of bladder tube | 44 | $72 | $353 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
41 | $35 | $273 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
36 | $133 | $535 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
35 | $117 | $618 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
35 | $24 | $107 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
33 | $320 | $1,336 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
32 | $43 | $238 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
30 | $241 | $795 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $41 | $129 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $75 | $331 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $104 | $421 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
20 | $94 | $467 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $105 | $432 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
19 | $166 | $815 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
19 | $185 | $730 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $46 | $604 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
18 | $15 | $61 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
13 | $40 | $121 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
5.2% medium
92.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,281
Total received (2018-2024)
Avg $1,612/year across 7 years
Top 14% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
180
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,984 (53.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,297 (47.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$951
2023
$1,815
2022
$1,870
2021
$329
2020
$5,040
2019
$823
2018
$454
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$159
Endo USA, Inc.
$100
Janssen Biotech, Inc.
$94
COLOPLAST CORP
$90
Myriad Genetic Laboratories, Inc.
$74
ABBVIE INC.
$68
180 Medical, Inc.
$65
Astellas Pharma US Inc
$38
Antares Pharma, Inc.
$33
UROGEN PHARMA, INC.
$30
Baxter Healthcare
$29
Olympus America Inc.
$28
Merck Sharp & Dohme LLC
$26
Sumitomo Pharma America, Inc.
$21
Tolmar, Inc.
$18
C. R. Bard, Inc. & Subsidiaries
$17
PROGENICS PHARMACEUTICALS, INC.
$17
Boston Scientific Corporation
$16
PROCEPT BioRobotics Corporation
$16
Photocure Inc
$13
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$7,121
Astellas Pharma US Inc
$470
Boston Scientific Corporation
$382
Myriad Genetic Laboratories, Inc.
$333
Medtronic USA, Inc.
$285
Sanara MedTech Inc.
$237
Axonics, Inc.
$228
KARL STORZ Endoscopy-America
$195
ABBVIE INC.
$179
Bayer Healthcare Pharmaceuticals Inc.
$159
Janssen Biotech, Inc.
$148
Endo Pharmaceuticals Inc.
$139
Merck Sharp & Dohme LLC
$134
Sumitomo Pharma America, Inc.
$129
180 Medical, Inc.
$124
Rochester Medical Corporation
$105
Endo USA, Inc.
$100
COLOPLAST CORP
$90
Olympus America Inc.
$60
Supernus Pharmaceuticals, Inc.
$50
ConvaTec Inc.
$48
UROVANT SCIENCES INC
$44
Myovant Sciences Inc.
$44
UroGen Pharma, Inc.
$40
Tolmar, Inc.
$40
Janssen Scientific Affairs, LLC
$39
Antares Pharma, Inc.
$33
UROGEN PHARMA, INC.
$30
C. R. Bard, Inc. & Subsidiaries
$30
BOSTON SCIENTIFIC CORPORATION
$30
Baxter Healthcare
$29
Hollister Incorporated
$26
TOLMAR Pharmaceuticals, Inc.
$23
Allergan, Inc.
$18
Aziyo Biologics, Inc.
$17
Laborie Medical Technologies Corp.
$17
PROGENICS PHARMACEUTICALS, INC.
$17
Allergan Inc.
$16
PROCEPT BioRobotics Corporation
$16
Calyxo, Inc.
$15
Dendreon Pharmaceuticals LLC
$14
PFIZER INC.
$13
Photocure Inc
$13
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 8.5 FR. X 675MM · ALTIS · AMS · AMS Ambicor · AQUABEAM SYSTEM · Aris · Axonics r-SNM System · BOTOX · BOTOX - UROLOGY · Bard InLay Optima Ureteral Stent with HydroGlide Guidewire · Bulkamid · CMOS VIDEO URETEROSCOPE · CVAC ASPIRATION SYSTEM · CYSVIEW · CellerateRx · ECM Patch · EDEX · ELIGARD · ERLEADA · Erleada · FLEXIBLE VIDEO URETHRO-CYSTOSCOPE · GEMTESA · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · INTERSTIM · INTERSTIM ICON · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · Luja Coude · MAGIC3 · Myrbetriq · Nubeqa · ORGOVYX · PERCLOT · PROLARIS · PROVENGE · PYLARIFY · Pouch · REZUM · SPEEDICATH · STONE CONE · Self-Cath · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · TLANDO · TOVIAZ · Titan · VaPro · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
29
Per 100K population
10.7
County median income
$70,578
Nearest hospital
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Klutke is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NC), with low-engagement industry engagement in the top 14% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Klutke experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Klutke performed 2,351 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Klutke receive payments from pharmaceutical companies?
Yes. Dr. Klutke received a total of $11,281 from 43 companies across 180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Klutke's costs compare to other urology physicians in Asheville?
Dr. Klutke's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Klutke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Asheville
Browse urology physicians in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology